(lp0
S'Clovis Oncology Stock-Drop Claims Still Fall Short, Court Told Law360  - 9 hours ago Law360, New York  -- Three underwriters accused of helping Clovis Oncology Inc. defraud investors in a stock offering asked a Colorado federal court Friday to dismiss claims against them, saying changes that were supposed&nbsp;...'
p1
aS'Clovis Oncology Inc  Earns Hold Rating from JPMorgan Chase &amp; Co. Chaffey Breeze - 15 hours ago Clovis Oncology Inc logo JPMorgan Chase &amp; Co. restated their hold rating on shares of Clovis Oncology Inc  in a report released on Wednesday morning.Option Market Alert: Clovis Oncology Inc Implied Price Swing Hits An Unsually ... - CML NewsStock Price Clovis Oncology, Inc.  Compared to Index - Highland Mirror'
p2
aS"Apple, Netflix, Clovis Oncology Upgraded Schaeffers Research  - Mar 15, 2017 Analysts are weighing in on iPhone maker Apple Inc. , &quot;FANG&quot; stock Netflix, Inc. , and cancer treatment specialist Clovis Oncology Inc . Here's a quick roundup of today's bullish brokerage notes on AAPL,&nbsp;...Analyst Activity  Chardan Capital Reiterates Sell on Clovis Oncology (NASDAQ ... - Market ExclusiveClovis Oncology Inc  Trading Up 5.8% on Analyst Upgrade - Chaffey Breeze"
p3
aS'Stock Volatility Risk Alert: Clovis Oncology Inc Realized Volatility Hits A ... CML News - 9 hours ago Before we cover the full analysis we make a quick alert here that Clovis Oncology Inc  has seen its stock price whip around at an escalated level.'
p4
aS'JP Morgan Boosts Price Target for Clovis Oncology Inc  on Back of ... Smarter Analyst - Feb 23, 2017 J.P. Morgan analyst Cory Kasimov is out with a new research report on shares of Neutral-rated Clovis Oncology Inc , raising the price target to $58 , after the drug maker released its fourth-quarter results, which provided some ...Commit To Purchase Clovis Oncology At $35, Earn 12.3% Using Options - NasdaqClovis Oncology Announces 2016 Operating Results - Yahoo Finance'
p5
aS"Buy or Sell? Average Brokerage Ratings on Clovis Oncology, Inc. (CLVS ... StockNewsJournal - 14 hours ago Investors who are keeping close eye on the stock of Clovis Oncology, Inc.  established that the company was able to keep return on investment at -74.54 in the trailing twelve month while Reuters data showed that industry's average stands ..."
p6
aS"Clovis Oncology Presents New Data from Phase 2 Studies of Rucaparib in ... Yahoo Finance - Mar 12, 2017 Clovis Oncology, Inc.  announced new data from parts 1 and 2 of the ongoing ARIEL2 Phase 2 study being presented today at the 2017 Society of Gynecologic Oncology  Annual Meeting on Women's Cancer in National Harbor, MD."
p7
aS"Average Brokerage Rating Of Nivalis Therapeutics, Inc. , Clovis Oncology ... The USA Commerce - Mar 15, 2017 Shares of Nivalis Therapeutics, Inc.  surged 1.37% to $2.96. During the trading on 03/14/2017, Company's stock ranged from $2.92 to $3.63."
p8
aS'Clovis Oncology Inc Risk Points versus Health Care CML News - Mar 8, 2017 This is a scatter plot analysis of the critical risk points from the option market for Clovis Oncology Inc  compared to its own past and the Health Care ETF.Traders Secrets on Telephone and Data Systems, Inc. , Clovis Oncology ... - StockNewsJournalCompany Performance of Clovis Oncology, Inc.  Increases 7.37% - Times Money'
p9
aS'Clovis Oncology Inc.  Breaks into New 52-Week High on March 15 Session Equities.com - Mar 15, 2017 Shares of Clovis Oncology Inc.  broke into a new 52-week high yesterday, hitting a peak of $73.81. Shares closed at $71.93 after opening at $66.95 for a move of 7.44%.'
p10
a.